Campbell Newman Asset Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.09M | Buy |
9,604
+416
| +5% | +$192K | 0.38% | 41 |
|
|
2026
Q1 | $4.41M | Buy |
9,188
+149
| +2% | +$76.3K | 0.36% | 42 |
|
|
2025
Q4 | $5.08M | Sell |
9,039
-348
| -4% | -$198K | 0.37% | 38 |
|
|
2025
Q3 | $4.83M | Buy |
9,387
+39
| +0.4% | +$17K | 0.35% | 41 |
|
|
2025
Q2 | $2.93M | Buy |
9,348
+622
| +7% | +$187K | 0.23% | 49 |
|
|
2025
Q1 | $2.66M | Sell |
8,726
-44
| -0.5% | -$14.8K | 0.23% | 49 |
|
|
2024
Q4 | $2.91M | Sell |
8,770
-27
| -0.3% | -$9.16K | 0.23% | 47 |
|
|
2024
Q3 | $2.94M | Sell |
8,797
-144
| -2% | -$54.7K | 0.22% | 50 |
|
|
2024
Q2 | $3.68M | Buy |
8,941
+27
| +0.3% | +$10.7K | 0.29% | 43 |
|
|
2024
Q1 | $3.6M | Sell |
8,914
-2,181
| -20% | -$767K | 0.29% | 41 |
|
|
2023
Q4 | $3.4M | Buy |
11,095
+46
| +0.4% | +$12.4K | 0.29% | 42 |
|
|
2023
Q3 | $2.68M | Sell |
11,049
-195
| -2% | -$49.9K | 0.25% | 44 |
|
|
2023
Q2 | $2.7M | Buy |
11,244
+246
| +2% | +$51.1K | 0.24% | 43 |
|
|
2023
Q1 | $2.07M | Buy |
10,998
+105
| +1% | +$21.7K | 0.2% | 51 |
|
|
2022
Q4 | $2.31M | Sell |
10,893
-5,207
| -32% | -$1.04M | 0.23% | 46 |
|
|
2022
Q3 | $2.53M | Buy |
16,100
+397
| +3% | +$63.4K | 0.28% | 40 |
|
|
2022
Q2 | $2.35M | Buy |
15,703
+722
| +5% | +$105K | 0.25% | 43 |
|
|
2022
Q1 | $2.45M | Buy |
14,981
+53
| +0.4% | +$8.74K | 0.24% | 45 |
|
|
2021
Q4 | $3.25M | Sell |
14,928
-265
| -2% | -$55.5K | 0.29% | 41 |
|
|
2021
Q3 | $2.88M | Sell |
15,193
-89
| -0.6% | -$16.2K | 0.29% | 44 |
|
|
2021
Q2 | $2.7M | Buy |
15,282
+928
| +6% | +$160K | 0.26% | 48 |
|
|
2021
Q1 | $2.35M | Buy |
14,354
+905
| +7% | +$138K | 0.25% | 51 |
|
|
2020
Q4 | $1.87M | Buy |
13,449
+1,184
| +10% | +$149K | 0.21% | 53 |
|
|
2020
Q3 | $1.37M | Buy |
12,265
+312
| +3% | +$36.1K | 0.18% | 59 |
|
|
2020
Q2 | $1.11M | Buy |
11,953
+281
| +2% | +$23.9K | 0.15% | 65 |
|
|
2020
Q1 | $856K | Sell |
11,672
-520
| -4% | -$45.1K | 0.15% | 63 |
|
|
2019
Q4 | $1.02M | Buy |
12,192
+121
| +1% | +$9.37K | 0.14% | 69 |
|
|
2019
Q3 | $1.01M | Sell |
12,071
-55
| -0.5% | -$4.16K | 0.15% | 65 |
|
|
2019
Q2 | $793K | Buy |
12,126
+1,040
| +9% | +$59.9K | 0.12% | 74 |
|
|
2019
Q1 | $654K | Buy |
11,086
+403
| +4% | +$24.1K | 0.1% | 88 |
|
|
2018
Q4 | $565K | Buy |
10,683
+1,391
| +15% | +$76.4K | 0.1% | 86 |
|
|
2018
Q3 | $557K | Buy |
+9,292
| New | +$508K | 0.08% | 101 |
|
Other funds holding MEDP
WA
Campbell Newman Asset Management's MEDP Position: Q2 2026 in Review
Campbell Newman Asset Management increased its Medpace (MEDP) stake by 4.5% in Q2 2026, buying an estimated $192K and bringing the position to 9,604 shares worth $5.09M. The position accounts for 0.38% of the portfolio, ranked #41.
Campbell Newman Asset Management first reported a position in MEDP in Q3 2018 and has held it in 32 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Campbell Newman Asset Management held 9,604 shares of Medpace worth $5.09M as of Q2 2026.
- Campbell Newman Asset Management bought 416 Medpace shares in Q2 2026, an estimated $192K.
- Medpace made up 0.38% of Campbell Newman Asset Management's portfolio in Q2 2026, its #41 holding.
- Campbell Newman Asset Management first reported a position in Medpace in Q3 2018 and has held it in 32 quarters since.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Campbell Newman Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.